339 related articles for article (PubMed ID: 34521187)
1. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.
Civriz Bozdağ S; Cengiz Seval G; Yönal Hindilerden İ; Hindilerden F; Andıç N; Baydar M; Aydın Kaynar L; Toprak SK; Göksoy HS; Balık Aydın B; Demirci U; Can F; Özkocaman V; Gündüz E; Güven ZT; Özkurt ZN; Demircioğlu S; Beksaç M; İnce İ; Yılmaz U; Eroğlu Küçükdiler H; Abishov E; Yavuz B; Ataş Ü; Mutlu YG; Baş V; Özkalemkaş F; Üsküdar Teke H; Gürsoy V; Çelik S; Çiftçiler R; Yağcı M; Topçuoğlu P; Çeneli Ö; Abbasov H; Selim C; Ar MC; Yücel OK; Sadri S; Albayrak C; Demir AM; Güler N; Keklik M; Terzi H; Doğan A; Yegin ZA; Kurt Yüksel M; Sadri S; Yavaşoğlu İ; Beköz HS; Aksu T; Maral S; Erol V; Kaynar L; İlhan O; Bolaman AZ; Sevindik ÖG; Akyay A; Özcan M; Gürman G; Ünal Ş; Yavuz Y; Diz Küçükkaya R; Özsan GH
Turk J Haematol; 2022 Feb; 39(1):43-54. PubMed ID: 34521187
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study.
Węcławek-Tompol J; Zakrzewska Z; Gryniewicz-Kwiatkowska O; Pierlejewski F; Bień E; Zaucha-Prażmo A; Zając-Spychała O; Szmydki-Baran A; Mizia-Malarz A; Bal W; Sawicka-Żukowska M; Kruk A; Ociepa T; Raciborska A; Książek A; Szczepański T; Peregud-Pogorzelski J; Krawczuk-Rybak M; Chaber R; Matysiak M; Wachowiak J; Irga-Jaworska N; Młynarski W; Dembowska-Bagińska B; Balwierz W; Matkowska-Kocjan A; Kazanowska B; Styczyński J; Ussowicz M
J Hematol Oncol; 2021 Oct; 14(1):163. PubMed ID: 34635137
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.
Duška F; Waldauf P; Halačová M; Zvoníček V; Bala J; Balík M; Beneš J; Klementová O; Kozáková I; Kubricht V; Le Roy A; Vymazal T; Řehořová V; Černý V;
Trials; 2020 Jul; 21(1):631. PubMed ID: 32641163
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub.
Wood WA; Neuberg DS; Thompson JC; Tallman MS; Sekeres MA; Sehn LH; Anderson KC; Goldberg AD; Pennell NA; Niemeyer CM; Tucker E; Hewitt K; Plovnick RM; Hicks LK
Blood Adv; 2020 Dec; 4(23):5966-5975. PubMed ID: 33278301
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study.
Goudsmit A; Cubilier E; Meert AP; Aftimos P; Stathopoulos K; Spilleboudt C; Loizidou A
Support Care Cancer; 2021 Nov; 29(11):6271-6278. PubMed ID: 33851236
[TBL] [Abstract][Full Text] [Related]
6. Impact of SARS-CoV-2 infection on patients with hematological malignancies: a retrospective study.
Zhao H; He Y; Li Z; Huang Y; Ying Y; Huang Z
Hematology; 2023 Dec; 28(1):2288480. PubMed ID: 38063157
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies.
Modemann F; Niederwieser C; Weisel K; Bokemeyer C; Fiedler W; Ghandili S
Leuk Lymphoma; 2022 Mar; 63(3):664-671. PubMed ID: 34668809
[TBL] [Abstract][Full Text] [Related]
8. "Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan".
Zaki A; Soomar SM; Khan DH; Shaharyar Sheikh H; Iftikhar R; Mir A; Aziz Z; Bano K; Naseer H; Chaudhry QU; Bokhari SWI; Shabbir-Moosajee M
PLoS One; 2022; 17(4):e0267139. PubMed ID: 35446898
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study.
Glenthøj A; Jakobsen LH; Sengeløv H; Ahmad SA; Qvist K; Rewes A; Poulsen CB; Overgaard UM; Mølle I; Severinsen MT; Strandholdt CN; Maibom J; Kodahl AR; Ryg J; Ravn P; Johansen IS; Helsø SN; Jensen-Fangel S; Kisielewicz J; Wiese L; Helleberg M; Kirk O; Clausen MR; Frederiksen H
Eur J Haematol; 2021 Jan; 106(1):72-81. PubMed ID: 32939853
[TBL] [Abstract][Full Text] [Related]
10. [SARS-COV-2 infection in patients with hematological malignancies and transplants].
Herrera F; Bues F; Rojas R; Temporiti E; Videla C; Dupont J; Bonvehí P
Medicina (B Aires); 2021; 81(3):396-400. PubMed ID: 34137699
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Pagano L; Salmanton-García J; Marchesi F; Busca A; Corradini P; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Verga L; Víšek B; Ilhan O; Nadali G; Weinbergerová B; Córdoba-Mascuñano R; Marchetti M; Collins GP; Farina F; Cattaneo C; Cabirta A; Gomes-Silva M; Itri F; van Doesum J; Ledoux MP; Čerňan M; Jakšić O; Duarte RF; Magliano G; Omrani AS; Fracchiolla NS; Kulasekararaj A; Valković T; Poulsen CB; Machado M; Glenthøj A; Stoma I; Ráčil Z; Piukovics K; Navrátil M; Emarah Z; Sili U; Maertens J; Blennow O; Bergantim R; García-Vidal C; Prezioso L; Guidetti A; Del Principe MI; Popova M; de Jonge N; Ormazabal-Vélez I; Fernández N; Falces-Romero I; Cuccaro A; Meers S; Buquicchio C; Antić D; Al-Khabori M; García-Sanz R; Biernat MM; Tisi MC; Sal E; Rahimli L; Čolović N; Schönlein M; Calbacho M; Tascini C; Miranda-Castillo C; Khanna N; Méndez GA; Petzer V; Novák J; Besson C; Duléry R; Lamure S; Nucci M; Zambrotta G; Žák P; Seval GC; Bonuomo V; Mayer J; López-García A; Sacchi MV; Booth S; Ciceri F; Oberti M; Salvini M; Izuzquiza M; Nunes-Rodrigues R; Ammatuna E; Obr A; Herbrecht R; Núñez-Martín-Buitrago L; Mancini V; Shwaylia H; Sciumè M; Essame J; Nygaard M; Batinić J; Gonzaga Y; Regalado-Artamendi I; Karlsson LK; Shapetska M; Hanakova M; El-Ashwah S; Borbényi Z; Çolak GM; Nordlander A; Dragonetti G; Maraglino AME; Rinaldi A; De Ramón-Sánchez C; Cornely OA;
J Hematol Oncol; 2021 Oct; 14(1):168. PubMed ID: 34649563
[TBL] [Abstract][Full Text] [Related]
12. The outcome of COVID-19 in patients with hematological malignancy.
Yigenoglu TN; Ata N; Altuntas F; Bascı S; Dal MS; Korkmaz S; Namdaroglu S; Basturk A; Hacıbekiroglu T; Dogu MH; Berber İ; Dal K; Erkurt MA; Turgut B; Ulgu MM; Celik O; Imrat E; Birinci S
J Med Virol; 2021 Feb; 93(2):1099-1104. PubMed ID: 32776581
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality.
Aumann S; Tsubary U; Nachmias B; Ben Yehuda D; Lavie D; Goldschmidt N; Vainstein V; Libster D; Saban R; Shaulov A; Israel S; Avni B; Grisariu S; Bdolah-Amram T; Gatt M; Zimran E
Eur J Haematol; 2023 Jul; 111(1):135-145. PubMed ID: 37096337
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Infection and Severity in Patients with Hematologic Malignancies: A Systematic Review.
SeyedAlinaghi S; Karimi A; Mirzapour P; Salmani R; Razi A; Mojdeganlou H; Mojdeganlou P; Qodrati M; Jashaninejad R; Paranjkhoo P; Dadras O; Zarezadeh B; Afsahi AM; Afzalian A; Varshochi S; Mehraeen E; Afsahi G
Infect Disord Drug Targets; 2023; 23(7):29-38. PubMed ID: 37138433
[TBL] [Abstract][Full Text] [Related]
15. Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group.
Palanques-Pastor T; Megías-Vericat JE; Martínez P; López Lorenzo JL; Cornago Navascués J; Rodriguez Macias G; Cano I; Arnan Sangerman M; Vidriales Vicente MB; Algarra Algarra JL; Foncillas MÁ; Herrera P; Botella Prieto C; Vives S; Figuera Álvarez Á; Cuevas Palomares L; Sobas M; Contento Gonzalo A; Cuello García R; Amutio Diez ME; De Miguel Llorente D; Navas Elorza B; Bergua Burgues JM; Bernal Del Castillo T; Mateos Rodríguez MC; de Cabo López E; Franco Villegas AC; García Boyero R; Escolano Escobar C; Seri Merino C; Cervero C; Roldán Pérez A; Hermosín Ramos L; Cervera Calvo M; Olave MT; Villafuerte Gutiérrez P; de Laiglesiai A; Serrano J; Najera Irazu MJ; Piñana JL; Sanz MÁ; Martínez-López J; Montesinos P
Leuk Lymphoma; 2021 Dec; 62(12):2928-2938. PubMed ID: 34292118
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review.
Meena JP; Kumar Gupta A; Tanwar P; Ram Jat K; Mohan Pandey R; Seth R
Pediatr Blood Cancer; 2021 Jun; 68(6):e29005. PubMed ID: 33719167
[TBL] [Abstract][Full Text] [Related]
17. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.
Saleh M; Gabriels J; Chang D; Soo Kim B; Mansoor A; Mahmood E; Makker P; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Chinitz J; Skipitaris N; Mountantonakis S; Epstein LM
Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008662. PubMed ID: 32347743
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 in hematological malignancies: Case series and literature review.
Ocheni S; Nwagha TU; Amu N; Obodo OI; Okereke K; Chikezie K; Ejezie CS; Ilechukwu GU; Obiatuegwu C
Ann Afr Med; 2023; 22(3):381-384. PubMed ID: 37417029
[TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies.
Wu TY; Tsai WT; Chen KH; Huang ST; Huang CF; Kuo PH; Tsai MJ; Liu WD; Lin KY; Huang YS; Cheng A; Chen PY; Sun HY; Huang HH; Huang TC; Wu SJ; Yao M; Wang JT; Sheng WH; Hung CC; Chen YC; Chang SC
J Microbiol Immunol Infect; 2024 Jun; 57(3):403-413. PubMed ID: 38480093
[TBL] [Abstract][Full Text] [Related]
20. Anesthetic Complications Associated With Severe Acute Respiratory Syndrome Coronavirus 2 in Pediatric Patients.
Saynhalath R; Alex G; Efune PN; Szmuk P; Zhu H; Sanford EL
Anesth Analg; 2021 Aug; 133(2):483-490. PubMed ID: 33886516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
